Get the Stockscreener App
19.40
0.62%
0.12
Oculis Holding Ag stock is traded at $19.40, with a volume of 178.52K.
It is up +0.62% in the last 24 hours and up +10.42% over the past month.
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
See More
Previous Close:
$19.28
Open:
$19.28
24h Volume:
178.52K
Relative Volume:
3.71
Market Cap:
$847.05M
Revenue:
-
Net Income/Loss:
$-75.28M
P/E Ratio:
-9.7209
EPS:
-1.9957
Net Cash Flow:
$-57.45M
1W Performance:
-10.00%
1M Performance:
+10.42%
6M Performance:
+2.81%
1Y Performance:
+8.50%
1-Day Range:
$19.00
$20.08
1-Week Range:
$19.00
$21.98
52-Week Range:
$14.00
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Compare OCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
19.40 | 1.01B | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.52 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.42 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.79 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.21 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.05 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Needham | Buy |
| Dec-05-23 | Initiated | Chardan Capital Markets | Buy |
| Oct-05-23 | Initiated | Stifel | Buy |
| Jun-14-23 | Initiated | BofA Securities | Buy |
| Jun-12-23 | Initiated | H.C. Wainwright | Buy |
| Jun-08-23 | Initiated | Robert W. Baird | Outperform |
| May-10-23 | Initiated | Pareto | Buy |
| Apr-28-23 | Initiated | Wedbush | Outperform |
View All
Oculis Holding Ag Stock (OCS) Latest News
Can Oculis Holding AG stock sustain market leadershipLong Setup & Weekly Market Pulse Alerts - newser.com
What does recent volatility data suggest for Oculis Holding AG Equity WarrantMarket Performance Summary & Advanced Technical Signal Analysis - newser.com
How to track smart money flows in Oculis Holding AG Equity WarrantEarnings Overview Report & Weekly Breakout Watchlists - newser.com
Using AI based signals to follow Oculis Holding AGMarket Growth Summary & AI Forecast for Swing Trade Picks - newser.com
Oculis Holding AG Equity Warrant stock trend outlook and recovery path2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
Can Oculis Holding AG Equity Warrant stock outperform in 2025 bull market2025 Sector Review & Technical Confirmation Trade Alerts - newser.com
Why retail investors pile into Oculis Holding AG Equity Warrant stockMarket Volume Report & Stock Timing and Entry Methods - newser.com
Why Oculis Holding AG Equity Warrant stock remains resilient2025 Biggest Moves & Verified Entry Point Signals - newser.com
Trend analysis for Oculis Holding AG Equity Warrant this weekTrend Reversal & Smart Allocation Stock Tips - newser.com
Will Oculis Holding AG stock outperform value stocksBreakout Watch & AI Based Buy/Sell Signal Reports - newser.com
Is Oculis Holding AG stock positioned for long term growthPortfolio Performance Summary & Community Driven Trade Alerts - newser.com
Why Oculis Holding AG Equity Warrant stock could outperform in 2025Portfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
Will Oculis Holding AG stock benefit from sector rotationJuly 2025 EndofMonth & High Conviction Buy Zone Picks - newser.com
Why retail investors favor Oculis Holding AG stockWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
Will a bounce in Oculis Holding AG offer an exitWeekly Trend Summary & Daily Volume Surge Signals - newser.com
Visualizing Oculis Holding AG Equity Warrant stock with heatmaps2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Will Oculis Holding AG stock gain from strong economyEarnings Beat & Target Return Focused Picks - newser.com
Why Oculis Holding AG Equity Warrant stock remains undervaluedJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
Can Oculis Holding AG Equity Warrant stock continue upward trendGlobal Markets & High Conviction Trade Alerts - newser.com
Applying Wyckoff theory to Oculis Holding AG Equity Warrant stockJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
How to monitor Oculis Holding AG Equity Warrant with trend dashboardsChart Signals & Low Volatility Stock Suggestions - newser.com
Published on: 2025-11-03 00:40:26 - newser.com
How to build a custom watchlist for Oculis Holding AGEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
How Oculis Holding AG stock compares to industry benchmarksIndex Update & Safe Entry Zone Tips - newser.com
How strong is Oculis Holding AG (CR5) stock earnings growthRate Cut & Daily Risk Controlled Trade Plans - newser.com
Evaluating Oculis Holding AG Equity Warrant with trendline analysis2025 Investor Takeaways & AI Powered Market Entry Ideas - newser.com
Why Oculis Holding (OCS) Is Raising $110 Million to Advance Privosegtor and What That Means for Investors - Yahoo Finance
Will Oculis Holding AG stock deliver shareholder valueDollar Strength & Short-Term Trading Alerts - newser.com
Is Oculis Holding AG CR5 a good long term investmentLarge Cap Stability Picks & Start Learning With Our Courses - earlytimes.in
Oculis Holding AG Secures $110 Million in Oversubscribed Share Offering - MSN
How Oculis Holding AG Equity Warrant stock performs in stagflation2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Using data models to predict Oculis Holding AG Equity Warrant stock movement2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com
Can Oculis Holding AG Equity Warrant stock beat market expectations this quarterMarket Movement Recap & Detailed Earnings Play Alerts - newser.com
Is Oculis Holding AG still worth holding after the dipOil Prices & Long-Term Growth Stock Strategies - newser.com
What momentum indicators show for Oculis Holding AG stockJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - newser.com
Oculis raises 110 million dollars to accelerate its development - Agefi.com
Is Oculis Holding AG stock a smart buy before Fed meeting2025 Market Trends & High Accuracy Buy Signal Tips - newser.com
Oculis Holding Ag Stock (OCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):